Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Banner Health
- Study ID
- NCT02022943
- Status
- Recruiting
Conditions
- Alzheimer's Disease
- Dementia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 110 Years
- Healthy Volunteers
- Accepted
Study Details
The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org
Key Dates
- Start date
- May 31, 2012
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 500,000 participants (estimated)
Primary Outcome Measure
Number of individuals enrolled into Alzheimer's prevention studies [ Time Frame: 16 years ]
Central Contacts
- Nellie High, MA1-888-STOP-ALZ
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | Jessica Langbaum, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
Related Studies
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)PHASE1/PHASE2 · Recruiting · AC Immune SA · Phoenix, Arizona
- Alzheimer's Disease Neuroimaging Initiative 4Enrolling By Invitation · University of Southern California · Birmingham, Alabama